Treatment of obesity with laparoscopic adjustable gastric banding in Singapore: an initial experience.
Laparoscopic adjustable gastric banding (LAGB) has been used for the treatment of obesity, being shown in western populations to be a safe and effective option. We present the results of our experience in the use of LAGB in the treatment of obesity. A retrospective review of all patients who underwent LAGB from February 1999 to June 2004 was made from a prospectively collected database. Pre-operative comorbidities, height, weight and body mass index (BMI) were recorded and compared with post-operative results. Operative times, length of stay and complications were also noted. 38 consecutive patients underwent LAGB. The 16 male and 22 female patients had a mean age of 37.6 years (range 19 to 62 years) and a mean BMI of 42.7 kg per square metre (range 28.8 to 78.4 kg per square metre). Nine were done utilising the perigastric approach, and the other 29 with the pars flaccida approach. There were no open conversions. Overall peri-operative morbidity was encountered in two (5.3 percent) patients, with a minor liver laceration and a capsular splenic laceration in separate patients. There were no post-operative complications. One (2.7 percent) patient had the band removed at 29 months post-operatively on request. There were no mortalities. Mean follow-up period was 13 months (range one to 56 months). Mean BMI decreased to 40.7, 38.7, 37.4, 34.1 and 32.9 kg per square metre, respectively, at one week, one, six, 12 and 18 months post-operatively. LAGB is a feasible modality in the multifaceted approach to treatment of morbid obesity. The results from our follow-up are comparable to larger series in western populations, with a similar safety profile.